Global Cancer Pain Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
137
Industry
Drugs by Therapeutic Area
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.

The global Cancer Pain market size was estimated at USD 6617.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Cancer Pain market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Cancer Pain market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Pain market.
Global Cancer Pain Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson?Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals

Market Segmentation (by Type)
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others

Market Segmentation (by Application)
Radiotherapy
Chemotherapy
Hormone Therapy
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Pain Market
Overview of the regional outlook of the Cancer Pain Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Pain Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Cancer Pain, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Cancer Pain
    • 1.2 Key Market Segments
      • 1.2.1 Cancer Pain Segment by Type
      • 1.2.2 Cancer Pain Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Cancer Pain Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Cancer Pain Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Cancer Pain Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Cancer Pain Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Cancer Pain Product Life Cycle
    • 3.3 Global Cancer Pain Sales by Manufacturers (2020-2025)
    • 3.4 Global Cancer Pain Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Cancer Pain Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Cancer Pain Market Competitive Situation and Trends
      • 3.8.1 Cancer Pain Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Cancer Pain Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Cancer Pain Industry Chain Analysis
    • 4.1 Cancer Pain Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Cancer Pain Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Cancer Pain Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy ? April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Cancer Pain Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Cancer Pain Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Cancer Pain Sales Market Share by Type (2020-2025)
    • 6.3 Global Cancer Pain Market Size by Type (2020-2025)
    • 6.4 Global Cancer Pain Price by Type (2020-2025)
  • 7 Cancer Pain Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Cancer Pain Market Sales by Application (2020-2025)
    • 7.3 Global Cancer Pain Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Cancer Pain Sales Growth Rate by Application (2020-2025)
  • 8 Cancer Pain Market Sales by Region
    • 8.1 Global Cancer Pain Sales by Region
      • 8.1.1 Global Cancer Pain Sales by Region
      • 8.1.2 Global Cancer Pain Sales Market Share by Region
    • 8.2 Global Cancer Pain Market Size by Region
      • 8.2.1 Global Cancer Pain Market Size by Region
      • 8.2.2 Global Cancer Pain Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Cancer Pain Sales by Country
      • 8.3.2 North America Cancer Pain Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Cancer Pain Sales by Country
      • 8.4.2 Europe Cancer Pain Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Cancer Pain Sales by Region
      • 8.5.2 Asia Pacific Cancer Pain Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Cancer Pain Sales by Country
      • 8.6.2 South America Cancer Pain Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Cancer Pain Sales by Region
      • 8.7.2 Middle East and Africa Cancer Pain Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Cancer Pain Market Production by Region
    • 9.1 Global Production of Cancer Pain by Region(2020-2025)
    • 9.2 Global Cancer Pain Revenue Market Share by Region (2020-2025)
    • 9.3 Global Cancer Pain Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Cancer Pain Production
      • 9.4.1 North America Cancer Pain Production Growth Rate (2020-2025)
      • 9.4.2 North America Cancer Pain Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Cancer Pain Production
      • 9.5.1 Europe Cancer Pain Production Growth Rate (2020-2025)
      • 9.5.2 Europe Cancer Pain Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Cancer Pain Production (2020-2025)
      • 9.6.1 Japan Cancer Pain Production Growth Rate (2020-2025)
      • 9.6.2 Japan Cancer Pain Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Cancer Pain Production (2020-2025)
      • 9.7.1 China Cancer Pain Production Growth Rate (2020-2025)
      • 9.7.2 China Cancer Pain Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 BioDelivery Science
      • 10.1.1 BioDelivery Science Basic Information
      • 10.1.2 BioDelivery Science Cancer Pain Product Overview
      • 10.1.3 BioDelivery Science Cancer Pain Product Market Performance
      • 10.1.4 BioDelivery Science Business Overview
      • 10.1.5 BioDelivery Science SWOT Analysis
      • 10.1.6 BioDelivery Science Recent Developments
    • 10.2 ProStrakan Group
      • 10.2.1 ProStrakan Group Basic Information
      • 10.2.2 ProStrakan Group Cancer Pain Product Overview
      • 10.2.3 ProStrakan Group Cancer Pain Product Market Performance
      • 10.2.4 ProStrakan Group Business Overview
      • 10.2.5 ProStrakan Group SWOT Analysis
      • 10.2.6 ProStrakan Group Recent Developments
    • 10.3 Teva pharmaceuticals
      • 10.3.1 Teva pharmaceuticals Basic Information
      • 10.3.2 Teva pharmaceuticals Cancer Pain Product Overview
      • 10.3.3 Teva pharmaceuticals Cancer Pain Product Market Performance
      • 10.3.4 Teva pharmaceuticals Business Overview
      • 10.3.5 Teva pharmaceuticals SWOT Analysis
      • 10.3.6 Teva pharmaceuticals Recent Developments
    • 10.4 Eli-Lilly
      • 10.4.1 Eli-Lilly Basic Information
      • 10.4.2 Eli-Lilly Cancer Pain Product Overview
      • 10.4.3 Eli-Lilly Cancer Pain Product Market Performance
      • 10.4.4 Eli-Lilly Business Overview
      • 10.4.5 Eli-Lilly Recent Developments
    • 10.5 Grunenthal Group
      • 10.5.1 Grunenthal Group Basic Information
      • 10.5.2 Grunenthal Group Cancer Pain Product Overview
      • 10.5.3 Grunenthal Group Cancer Pain Product Market Performance
      • 10.5.4 Grunenthal Group Business Overview
      • 10.5.5 Grunenthal Group Recent Developments
    • 10.6 GW Pharmaceuticals
      • 10.6.1 GW Pharmaceuticals Basic Information
      • 10.6.2 GW Pharmaceuticals Cancer Pain Product Overview
      • 10.6.3 GW Pharmaceuticals Cancer Pain Product Market Performance
      • 10.6.4 GW Pharmaceuticals Business Overview
      • 10.6.5 GW Pharmaceuticals Recent Developments
    • 10.7 Johnson?Johnson
      • 10.7.1 Johnson?Johnson Basic Information
      • 10.7.2 Johnson?Johnson Cancer Pain Product Overview
      • 10.7.3 Johnson?Johnson Cancer Pain Product Market Performance
      • 10.7.4 Johnson?Johnson Business Overview
      • 10.7.5 Johnson?Johnson Recent Developments
    • 10.8 Meda Pharmaceuticals
      • 10.8.1 Meda Pharmaceuticals Basic Information
      • 10.8.2 Meda Pharmaceuticals Cancer Pain Product Overview
      • 10.8.3 Meda Pharmaceuticals Cancer Pain Product Market Performance
      • 10.8.4 Meda Pharmaceuticals Business Overview
      • 10.8.5 Meda Pharmaceuticals Recent Developments
    • 10.9 Orexo
      • 10.9.1 Orexo Basic Information
      • 10.9.2 Orexo Cancer Pain Product Overview
      • 10.9.3 Orexo Cancer Pain Product Market Performance
      • 10.9.4 Orexo Business Overview
      • 10.9.5 Orexo Recent Developments
    • 10.10 Sanofi
      • 10.10.1 Sanofi Basic Information
      • 10.10.2 Sanofi Cancer Pain Product Overview
      • 10.10.3 Sanofi Cancer Pain Product Market Performance
      • 10.10.4 Sanofi Business Overview
      • 10.10.5 Sanofi Recent Developments
    • 10.11 WEX Pharmaceuticals
      • 10.11.1 WEX Pharmaceuticals Basic Information
      • 10.11.2 WEX Pharmaceuticals Cancer Pain Product Overview
      • 10.11.3 WEX Pharmaceuticals Cancer Pain Product Market Performance
      • 10.11.4 WEX Pharmaceuticals Business Overview
      • 10.11.5 WEX Pharmaceuticals Recent Developments
  • 11 Cancer Pain Market Forecast by Region
    • 11.1 Global Cancer Pain Market Size Forecast
    • 11.2 Global Cancer Pain Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Cancer Pain Market Size Forecast by Country
      • 11.2.3 Asia Pacific Cancer Pain Market Size Forecast by Region
      • 11.2.4 South America Cancer Pain Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Cancer Pain by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Cancer Pain Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Cancer Pain by Type (2026-2035)
      • 12.1.2 Global Cancer Pain Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Cancer Pain by Type (2026-2035)
    • 12.2 Global Cancer Pain Market Forecast by Application (2026-2035)
      • 12.2.1 Global Cancer Pain Sales (K MT) Forecast by Application
      • 12.2.2 Global Cancer Pain Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.